Abstract
After oral intake of drugs, drugs go through the first pass metabolism in the gut and the liver, which greatly affects the final outcome of the drugs’ efficacy and side effects. The first pass metabolism is a complex process involving the gut and the liver tissue, with transport and reaction occurring simultaneously at various locations, which makes it difficult to be reproduced in vitro with conventional cell culture systems. In an effort to tackle this challenge, here we have developed a microfluidic gut-liver chip that can reproduce the dynamics of the first pass metabolism. The microfluidic chip consists of two separate layers for gut epithelial cells (Caco-2) and the liver cells (HepG2), and is designed so that drugs go through a sequential absorption in the gut chamber and metabolic reaction in the liver chamber. We fabricated the chip and showed that the two different cell lines can be successfully co-cultured on chip. When the two cells are cultured on chip, changes in the physiological function of Caco-2 and HepG2 cells were noted. The cytochrome P450 metabolic activity of both cells were significantly enhanced, and the absorptive property of Caco-2 cells on chip also changed in response to the presence of flow. Finally, first pass metabolism of a flavonoid, apigenin, was evaluated as a model compound, and co-culture of gut and liver cells on chip resulted in a metabolic profile that is closer to the reported profile than a monoculture of gut cells. This microfluidic gut-liver chip can potentially be a useful platform to study the complex first pass metabolism of drugs in vitro.
Similar content being viewed by others
References
A. Abbott, Nature 424, 870 (2003)
T.A. Aguirre, M. Rosa, S.S. Guterres, A.R. Pohlmann, I. Coulter, D.J. Brayden, Eur. J. Pharm. Biopharm. 88, 856 (2014)
J.W. Allen, S.R. Khetani, S.N. Bhatia, Toxicol. Sci. 84, 110 (2005)
P. Artursson, K. Palm, K. Luthman, Adv. Drug Deliv. Rev. 46, 27 (2001)
S.H. Au, M.D. Chamberlain, S. Mahesh, M.V. Sefton, A.R. Wheeler, Lab Chip 14, 3290 (2014)
E. Berthier, E.W. Young, D. Beebe, Lab Chip 12, 1224 (2012)
S.N. Bhatia, D.E. Ingber, Nat. Biotechnol. 32, 760 (2014)
R. Booth, H. Kim, Lab Chip 12, 1784 (2012)
E.F. Brandon, C.D. Raap, I. Meijerman, J.H. Beijnen, J.H. Schellens, Toxicol. Appl. Pharmacol. 189, 233 (2003)
T.J. Carlson, M.B. Fisher, Comb. Chem. High Throughput Screen. 11, 258 (2008)
C.Y. Chan, P.H. Huang, F. Guo, X. Ding, V. Kapur, J.D. Mai, P.K. Yuen, T.J. Huang, Lab Chip 13, 4697 (2013)
J. Chen, H. Lin, M. Hu, J. Pharmacol. Exp. Ther. 304, 1228 (2003)
M. Chi, B. Yi, S. Oh, D.J. Park, J.H. Sung, S. Park, Biomed. Microdevices 17, 9966 (2015)
S. Choi, M. Nishikawa, A. Sakoda, Y. Sakai, Toxicol. In Vitro 18, 393 (2004)
M.B. Esch, G.J. Mahler, T. Stokol, M.L. Shuler, Lab Chip 14, 3081 (2014)
S. Ferruzza, C. Rossi, M.L. Scarino, Y. Sambuy, Toxicol. In Vitro 26, 1252 (2012)
K.D. Fine, C.A. Santa Ana, J.L. Porter, J.S. Fordtran, Gastroenterology 108, 983 (1995)
A. Galetin, J.B. Houston, J. Pharmacol. Exp. Ther. 318, 1220 (2006)
A. Gradolatto, M.C. Canivenc-Lavier, J.P. Basly, M.H. Siess, C. Teyssier, Drug Metab. Dispos. 32, 58 (2004)
H.F. Helander, L. Fandriks, Scand. J. Gastroenterol. 49, 681 (2014)
C. Hilgendorf, H. Spahn-Langguth, C.G. Regardh, E. Lipka, G.L. Amidon, P. Langguth, J. Pharm. Sci. 89, 63 (2000)
M. Hu, J. Chen, H. Lin, J. Pharmacol. Exp. Ther. 307, 314 (2003)
B. Hughes, Nat. Rev. Drug Discov. 8, 93 (2009)
Y. Imura, K. Sato, E. Yoshimura, Anal. Chem. 82, 9983 (2010)
Y. Imura, E. Yoshimura, K. Sato, Anal. Sci. 28, 197 (2012)
K.I. Kaitin, Clin. Pharmacol. Ther. 87, 356 (2010)
S.R. Khetani, D.R. Berger, K.R. Ballinger, M.D. Davidson, C. Lin, B.R. Ware, J Lab Autom. 20, 216 (2015)
H.J. Kim, D. Huh, G. Hamilton, D.E. Ingber, Lab Chip 12, 2165 (2012)
S.H. Kim, J.W. Lee, I. Choi, Y.C. Kim, J.B. Lee, J.H. Sung, J. Nanosci. Nanotechnol. 13, 7220 (2013)
H. Lee, D. S. Kim, S. K. Ha, I. Choi, J. M. Lee, J. H. Sung, Biotechnol. Bioeng. (2016)
P. Martin, R. Riley, D.J. Back, A. Owen, Br. J. Pharmacol. 153, 805 (2008)
C. Masungi, C. Borremans, B. Willems, J. Mensch, A. Van Dijck, P. Augustijns, M.E. Brewster, M. Noppe, J. Pharm. Sci. 93, 2507 (2004)
C. Moraes, J.M. Labuz, B.M. Leung, M. Inoue, T.H. Chun, S. Takayama, Integr Biol (Camb) 5, 1149 (2013)
D. Moutinho, C.C. Marohnic, S.P. Panda, J. Rueff, B.S. Masters, M. Kranendonk, Drug Metab. Dispos. 40, 754 (2012)
K. Naruhashi, I. Tamai, Q. Li, Y. Sai, A. Tsuji, J. Pharm. Sci. 92, 1502 (2003)
D. Patel, S. Shukla, S. Gupta, Int. J. Oncol. 30, 233 (2007)
J.M. Prot, C. Aninat, L. Griscom, F. Razan, C. Brochot, C.G. Guillouzo, C. Legallais, A. Corlu, E. Leclerc, Biotechnol. Bioeng. 108, 1704 (2011)
A. Sivaraman, J.K. Leach, S. Townsend, T. Iida, B.J. Hogan, D.B. Stolz, R. Fry, L.D. Samson, S.R. Tannenbaum, L.G. Griffith, Curr. Drug Metab. 6, 569 (2005)
D. Spaggiari, L. Geiser, Y. Daali, S. Rudaz, J. Pharm. Biomed. Anal. 101, 221 (2014)
J. Strovel, S. Sittampalam, N.P. Coussens, M. Hughes, J. Inglese, A. Kurtz, A. Andalibi, L. Patton, C. Austin, M. Baltezor, M. Beckloff, M. Weingarten, S. Weir, in Assay Guidance Manual, ed by G. S. Sittampalam, N. P. Coussens, H. Nelson, et al.. Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, 2004)
J.H. Sung, M.L. Shuler, Lab Chip 9, 1385 (2009)
J.H. Sung, C. Kam, M.L. Shuler, Lab Chip 10, 446 (2010)
J.H. Sung, M.B. Esch, J.M. Prot, C.J. Long, A. Smith, J.J. Hickman, M.L. Shuler, Lab Chip 13, 1201 (2013)
Z. Teng, C. Yuan, F. Zhang, M. Huan, W. Cao, K. Li, J. Yang, D. Cao, S. Zhou, Q. Mei, PLoS One 7, e29647 (2012)
D. Ulluwishewa, R.C. Anderson, W.C. McNabb, P.J. Moughan, J.M. Wells, N.C. Roy, J. Nutr. 141, 769 (2011)
P.M. van Midwoud, M.T. Merema, E. Verpoorte, G.M. Groothuis, Lab Chip 10, 2778 (2010)
B. Vinci, C. Duret, S. Klieber, S. Gerbal-Chaloin, A. Sa-Cunha, S. Laporte, B. Suc, P. Maurel, A. Ahluwalia, M. Daujat-Chavanieu, Biotechnol. J. 6, 554 (2011)
L. Wang, S.K. Murthy, W.H. Fowle, G.A. Barabino, R.L. Carrier, Biomaterials 30, 6825 (2009)
W.M. Westerink, W.G. Schoonen, Toxicol. In Vitro 21, 1581 (2007)
J.P. Wikswo, E.L. Curtis, Z.E. Eagleton, B.C. Evans, A. Kole, L.H. Hofmeister, W.J. Matloff, Lab Chip 13, 3496 (2013)
O.L. Woodman, E. Chan, Clin. Exp. Pharmacol. Physiol. 31, 786 (2004)
E.W. Young, C.A. Simmons, Lab Chip 10, 143 (2010)
Acknowledgements
This work was supported by Ministry of Trade, Industry and Energy (MOTIE), Republic of Korea (10050154, Establishment of Infrastructure for industrialization of Korean Useful Microbes, R0004073), and KFRI (Korea Food Research Institute, grant no: E0121705), and Hongik University Research Fund. This work was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2016R1A2B2008691) and by the KIST Institutional Program (No. 2 V04950).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Choe, A., Ha, S.K., Choi, I. et al. Microfluidic Gut-liver chip for reproducing the first pass metabolism. Biomed Microdevices 19, 4 (2017). https://doi.org/10.1007/s10544-016-0143-2
Published:
DOI: https://doi.org/10.1007/s10544-016-0143-2